Michael Steward

Whittington Hospital — United Kingdom

Medicine · Health Sciences

47h-index6.8kcitations200works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(67), Virology and Viral Diseases(30), Respiratory viral infections research(24), vaccines and immunoinformatics approaches(22), Glycosylation and Glycoproteins Research(21)

Publications200 total

Good spots: diagnostic value at the edge of the slice
The Royal College of Radiologists Open·2025Open Access
Supplemental Figure Legend from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Data from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Supplementary Figure 1 and Table 1 from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Data from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Supplemental Figure Legend from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Supplementary Figure 1 and Table 1 from Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
2023Open Access
Perceptions of Resilience in Fishery-Dependent Bahamian Communities Following a Category 4 Hurricane
Fisheries·2019· 14 cited
‘In-Format’ screening of a novel bispecific antibody format reveals significant potency improvements relative to unformatted molecules
mAbs·2016· 12 citedOpen Access
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
Molecular Cancer Research·2016· 28 citedOpen Access
Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept
Journal of Biological Chemistry·2016· 20 citedOpen Access
Recombinant, truncated B. circulans keratanase-II: Description and characterisation of a novel enzyme for use in measuring urinary keratan sulphate levels via LC–MS/MS in Morquio A syndrome
Clinical Biochemistry·2015· 9 citedOpen Access
Using satellite altimetry and tide gauges for storm surge warning
Proceedings of the International Association of Hydrological Sciences·2015· 4 citedOpen Access
Tide Gauge And Satellite Altimetry Integration For Storm Surge Prediction
Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)·2013· 1 cited
A dual‐targeting antibody against EGFR‐VEGF for lung and head and neck cancer treatment
International Journal of Cancer·2011· 34 citedOpen Access
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice
Cancer Chemotherapy and Pharmacology·2011· 8 cited
Rooting morphology and salinity/pH interactions in monolayer soil covers above copper tailings
Open Collections·2011Open Access
Erratum / News Items
International Archives of Allergy and Applied Immunology·2009Open Access
A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways
Blood·2009· 140 citedOpen Access
Abstract #LB-163: A novel antiangiogenic feature of a dual targeting antibody (DMS3008) against EGFR and VEGF
Cancer Research·2009
page 1 of 10Next →

Frequent Co-authors

Carolynne Stanley(9), Colin R. Howard(6), Charalambos D. Partidos(6), J F Soothill(4), S E Brown(4), Obeid E. Obeid(4), Peter T. Emmerson(3), Andrew M. Lew(3), Frank Dudbridge(3), Nicholas A. Watkins(3), Willem H. Ouwehand(3), Arie J. Zuckerman(3), Ross E. Petty(3), Iain C. Macaulay(2), Philippa Burns(2), Jaap Jan Zwaginga(2), Chris I. Jones(2), Sarah Bray(2), Stephen F. Garner(2), Bernard de Bono(2)